Drug Type Small molecule drug |
Synonyms HL- 013XC, HL-013 |
Target |
Action antagonists, inhibitors |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23ClN6O |
InChIKeyPSIFNNKUMBGKDQ-UHFFFAOYSA-N |
CAS Registry114798-26-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Phase 1 | - | - | |
| Hypertension | Phase 1 | - | - |





